 Virginia Ferguson
Concepts (445)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cartilage, Articular | 12 | 2022 | 306 | 3.310 |
Why?
| | Bone and Bones | 12 | 2020 | 290 | 2.700 |
Why?
| | Space Flight | 18 | 2021 | 129 | 2.380 |
Why?
| | Weightlessness | 11 | 2021 | 80 | 2.200 |
Why?
| | Growth Plate | 3 | 2022 | 34 | 1.680 |
Why?
| | Osteocytes | 6 | 2022 | 22 | 1.570 |
Why?
| | Hindlimb Suspension | 8 | 2013 | 24 | 1.410 |
Why?
| | Bone Remodeling | 6 | 2021 | 64 | 1.320 |
Why?
| | Biomechanical Phenomena | 18 | 2020 | 683 | 1.250 |
Why?
| | Finite Element Analysis | 10 | 2019 | 70 | 1.180 |
Why?
| | Collagen | 7 | 2020 | 433 | 1.140 |
Why?
| | Cortical Bone | 4 | 2020 | 18 | 1.130 |
Why?
| | Muscular Atrophy | 5 | 2020 | 80 | 1.120 |
Why?
| | Calcification, Physiologic | 9 | 2020 | 34 | 1.110 |
Why?
| | Bone Diseases, Metabolic | 4 | 2021 | 60 | 1.110 |
Why?
| | Osteoarthritis | 3 | 2016 | 176 | 1.060 |
Why?
| | Cartilage | 4 | 2022 | 184 | 1.020 |
Why?
| | Splenic Artery | 4 | 2016 | 13 | 0.970 |
Why?
| | Glycosaminoglycans | 5 | 2021 | 78 | 0.940 |
Why?
| | Animals | 67 | 2023 | 33399 | 0.930 |
Why?
| | Muscle, Skeletal | 11 | 2020 | 1523 | 0.910 |
Why?
| | Mechanical Phenomena | 4 | 2018 | 86 | 0.910 |
Why?
| | Extracellular Matrix | 5 | 2022 | 446 | 0.910 |
Why?
| | Umbilical Arteries | 2 | 2013 | 38 | 0.880 |
Why?
| | Aging | 6 | 2019 | 1677 | 0.860 |
Why?
| | Mice, Inbred C57BL | 27 | 2021 | 4914 | 0.840 |
Why?
| | Tibia | 9 | 2022 | 177 | 0.830 |
Why?
| | Osteoporosis | 3 | 2020 | 229 | 0.800 |
Why?
| | Elasticity | 8 | 2017 | 193 | 0.790 |
Why?
| | Hydrogels | 8 | 2022 | 584 | 0.790 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2019 | 590 | 0.780 |
Why?
| | Femur | 11 | 2021 | 199 | 0.740 |
Why?
| | Bone Density | 14 | 2022 | 449 | 0.730 |
Why?
| | Sepharose | 2 | 2017 | 33 | 0.720 |
Why?
| | Hindlimb | 4 | 2021 | 137 | 0.720 |
Why?
| | Fetal Growth Retardation | 3 | 2013 | 468 | 0.710 |
Why?
| | Fractures, Bone | 3 | 2021 | 380 | 0.670 |
Why?
| | Physical Conditioning, Animal | 3 | 2010 | 204 | 0.660 |
Why?
| | Polyethylene Glycols | 6 | 2022 | 578 | 0.640 |
Why?
| | Tissue Engineering | 7 | 2022 | 363 | 0.640 |
Why?
| | Vascular Stiffness | 2 | 2013 | 425 | 0.640 |
Why?
| | Tissue Scaffolds | 3 | 2021 | 184 | 0.630 |
Why?
| | Mice | 38 | 2023 | 15528 | 0.620 |
Why?
| | Models, Theoretical | 2 | 2017 | 556 | 0.560 |
Why?
| | Muscle Strength | 3 | 2020 | 283 | 0.550 |
Why?
| | Macrophage Colony-Stimulating Factor | 3 | 2011 | 18 | 0.550 |
Why?
| | Cancellous Bone | 4 | 2020 | 21 | 0.530 |
Why?
| | Cervix Uteri | 1 | 2015 | 48 | 0.520 |
Why?
| | Water | 2 | 2016 | 425 | 0.510 |
Why?
| | Carotid Arteries | 2 | 2013 | 184 | 0.500 |
Why?
| | Chondrocytes | 1 | 2016 | 206 | 0.480 |
Why?
| | Stress, Mechanical | 7 | 2022 | 443 | 0.480 |
Why?
| | Aorta, Abdominal | 1 | 2013 | 40 | 0.470 |
Why?
| | Insulin-Like Growth Factor I | 3 | 2013 | 287 | 0.470 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2018 | 710 | 0.460 |
Why?
| | Muscle Fatigue | 2 | 2013 | 91 | 0.460 |
Why?
| | Software | 1 | 2018 | 613 | 0.460 |
Why?
| | Intervertebral Disc | 1 | 2013 | 37 | 0.450 |
Why?
| | Adaptation, Biological | 1 | 2013 | 57 | 0.450 |
Why?
| | Tooth Wear | 1 | 2012 | 18 | 0.430 |
Why?
| | Dental Enamel | 1 | 2012 | 64 | 0.430 |
Why?
| | Neurophysiology | 1 | 2012 | 16 | 0.420 |
Why?
| | Anisotropy | 3 | 2016 | 65 | 0.420 |
Why?
| | Lemur | 1 | 2012 | 50 | 0.420 |
Why?
| | Horses | 2 | 2009 | 106 | 0.400 |
Why?
| | Lumbar Vertebrae | 1 | 2013 | 215 | 0.400 |
Why?
| | Aorta, Thoracic | 1 | 2013 | 248 | 0.400 |
Why?
| | Haversian System | 1 | 2010 | 2 | 0.390 |
Why?
| | Swine | 7 | 2019 | 731 | 0.380 |
Why?
| | Cartilage Diseases | 2 | 2019 | 47 | 0.380 |
Why?
| | Pre-Eclampsia | 1 | 2013 | 183 | 0.380 |
Why?
| | Porosity | 3 | 2020 | 93 | 0.360 |
Why?
| | Bone Development | 4 | 2004 | 53 | 0.350 |
Why?
| | Electric Stimulation | 2 | 2013 | 268 | 0.350 |
Why?
| | Gene Expression Regulation | 6 | 2019 | 2446 | 0.340 |
Why?
| | Spleen | 5 | 2017 | 510 | 0.340 |
Why?
| | Metacarpal Bones | 1 | 2008 | 13 | 0.330 |
Why?
| | Umbilical Cord | 1 | 2009 | 84 | 0.330 |
Why?
| | Regenerative Medicine | 2 | 2019 | 46 | 0.320 |
Why?
| | Female | 38 | 2023 | 61588 | 0.320 |
Why?
| | X-Ray Microtomography | 3 | 2019 | 79 | 0.310 |
Why?
| | Osteoblasts | 4 | 2020 | 115 | 0.310 |
Why?
| | Male | 29 | 2021 | 57818 | 0.300 |
Why?
| | Exercise Test | 2 | 2013 | 551 | 0.300 |
Why?
| | Bone Diseases | 2 | 2018 | 59 | 0.300 |
Why?
| | Osteogenesis | 2 | 2019 | 213 | 0.300 |
Why?
| | Compressive Strength | 3 | 2019 | 73 | 0.290 |
Why?
| | Thymus Gland | 4 | 2013 | 300 | 0.290 |
Why?
| | Recovery of Function | 1 | 2010 | 604 | 0.280 |
Why?
| | Range of Motion, Articular | 1 | 2008 | 369 | 0.280 |
Why?
| | Cattle | 3 | 2022 | 979 | 0.280 |
Why?
| | Tensile Strength | 3 | 2015 | 105 | 0.280 |
Why?
| | Phantoms, Imaging | 2 | 2018 | 139 | 0.270 |
Why?
| | Elastic Modulus | 3 | 2016 | 118 | 0.270 |
Why?
| | Arteries | 3 | 2018 | 250 | 0.270 |
Why?
| | Microscopy, Confocal | 2 | 2018 | 314 | 0.270 |
Why?
| | Materials Testing | 4 | 2016 | 359 | 0.260 |
Why?
| | Elasticity Imaging Techniques | 2 | 2016 | 44 | 0.260 |
Why?
| | Imaging, Three-Dimensional | 2 | 2019 | 499 | 0.260 |
Why?
| | Models, Biological | 4 | 2016 | 1715 | 0.250 |
Why?
| | Rabbits | 3 | 2022 | 780 | 0.250 |
Why?
| | Pregnancy | 6 | 2015 | 5694 | 0.250 |
Why?
| | Printing, Three-Dimensional | 3 | 2022 | 63 | 0.250 |
Why?
| | Algorithms | 3 | 2018 | 1543 | 0.240 |
Why?
| | Neurons | 1 | 2012 | 1345 | 0.240 |
Why?
| | Body Composition | 2 | 2021 | 653 | 0.230 |
Why?
| | Femur Head | 1 | 2003 | 41 | 0.230 |
Why?
| | Models, Cardiovascular | 2 | 2016 | 180 | 0.230 |
Why?
| | Physical Examination | 1 | 2005 | 243 | 0.230 |
Why?
| | Osteoclasts | 2 | 2020 | 36 | 0.230 |
Why?
| | Elastin | 2 | 2013 | 77 | 0.230 |
Why?
| | Temperature | 2 | 2018 | 622 | 0.220 |
Why?
| | Pelvic Floor | 1 | 2023 | 24 | 0.220 |
Why?
| | Computer Simulation | 3 | 2016 | 922 | 0.220 |
Why?
| | Pelvic Organ Prolapse | 1 | 2023 | 41 | 0.220 |
Why?
| | Bone Resorption | 3 | 2015 | 80 | 0.220 |
Why?
| | Disease Models, Animal | 8 | 2019 | 3730 | 0.210 |
Why?
| | Sheep | 3 | 2013 | 764 | 0.210 |
Why?
| | Stereolithography | 2 | 2021 | 8 | 0.210 |
Why?
| | Esters | 1 | 2022 | 61 | 0.210 |
Why?
| | Dinoprostone | 1 | 2022 | 193 | 0.210 |
Why?
| | Pressure | 4 | 2015 | 226 | 0.200 |
Why?
| | Sialoglycoproteins | 1 | 2002 | 162 | 0.200 |
Why?
| | Biomimetics | 1 | 2021 | 38 | 0.200 |
Why?
| | Humans | 32 | 2022 | 119032 | 0.200 |
Why?
| | Glycation End Products, Advanced | 1 | 2021 | 67 | 0.200 |
Why?
| | Exercise Therapy | 1 | 2005 | 357 | 0.190 |
Why?
| | Second Harmonic Generation Microscopy | 1 | 2020 | 3 | 0.190 |
Why?
| | Nursing Care | 1 | 2001 | 30 | 0.190 |
Why?
| | Quantitative Trait Loci | 1 | 2022 | 324 | 0.190 |
Why?
| | Multiple Myeloma | 1 | 2002 | 100 | 0.190 |
Why?
| | Calcinosis | 1 | 2003 | 282 | 0.190 |
Why?
| | Myosin Heavy Chains | 2 | 2013 | 192 | 0.190 |
Why?
| | Bone Matrix | 2 | 2019 | 8 | 0.190 |
Why?
| | United States National Aeronautics and Space Administration | 1 | 2020 | 4 | 0.190 |
Why?
| | Hardness Tests | 2 | 2010 | 2 | 0.180 |
Why?
| | Spectrum Analysis, Raman | 1 | 2020 | 43 | 0.180 |
Why?
| | Weightlessness Simulation | 1 | 2020 | 13 | 0.180 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2015 | 196 | 0.180 |
Why?
| | Myostatin | 1 | 2020 | 26 | 0.180 |
Why?
| | Aerospace Medicine | 1 | 2020 | 20 | 0.180 |
Why?
| | Salter-Harris Fractures | 1 | 2019 | 10 | 0.180 |
Why?
| | Organ Size | 5 | 2013 | 460 | 0.180 |
Why?
| | Fracture Healing | 1 | 2020 | 74 | 0.180 |
Why?
| | Scattering, Small Angle | 1 | 2019 | 20 | 0.180 |
Why?
| | Liver | 3 | 2017 | 1816 | 0.170 |
Why?
| | Ligation | 2 | 2016 | 82 | 0.170 |
Why?
| | Disease Progression | 2 | 2016 | 2490 | 0.170 |
Why?
| | Oxidative Stress | 4 | 2018 | 1179 | 0.170 |
Why?
| | X-Ray Diffraction | 1 | 2019 | 86 | 0.170 |
Why?
| | Body Weight | 5 | 2016 | 934 | 0.160 |
Why?
| | Reproducibility of Results | 2 | 2019 | 2874 | 0.160 |
Why?
| | Lipid Bilayers | 1 | 2019 | 100 | 0.160 |
Why?
| | Polymers | 1 | 2022 | 482 | 0.160 |
Why?
| | Osteoarthritis, Knee | 1 | 2021 | 223 | 0.160 |
Why?
| | Knee Joint | 1 | 2021 | 353 | 0.160 |
Why?
| | Physical Exertion | 2 | 2012 | 222 | 0.150 |
Why?
| | Gene Expression | 4 | 2022 | 1492 | 0.150 |
Why?
| | Adrenal Glands | 1 | 2017 | 72 | 0.150 |
Why?
| | Osteoprotegerin | 2 | 2015 | 23 | 0.150 |
Why?
| | Actins | 4 | 2020 | 404 | 0.140 |
Why?
| | Rats | 5 | 2021 | 5394 | 0.140 |
Why?
| | Regression Analysis | 1 | 2019 | 984 | 0.140 |
Why?
| | Diffusion | 1 | 2016 | 122 | 0.140 |
Why?
| | Permeability | 1 | 2016 | 156 | 0.140 |
Why?
| | Sex Characteristics | 1 | 2021 | 671 | 0.140 |
Why?
| | Femoral Neck Fractures | 1 | 2016 | 23 | 0.140 |
Why?
| | Energy Intake | 1 | 1999 | 448 | 0.140 |
Why?
| | Genome-Wide Association Study | 1 | 2022 | 1323 | 0.140 |
Why?
| | Wound Healing | 1 | 2017 | 270 | 0.130 |
Why?
| | Immunoglobulin Fc Fragments | 1 | 2015 | 35 | 0.130 |
Why?
| | Kidney Function Tests | 1 | 2016 | 164 | 0.130 |
Why?
| | Hemostatic Techniques | 1 | 2015 | 40 | 0.130 |
Why?
| | Weight-Bearing | 3 | 2021 | 172 | 0.130 |
Why?
| | Tissue Preservation | 1 | 2014 | 13 | 0.130 |
Why?
| | Environment | 2 | 2014 | 346 | 0.130 |
Why?
| | Muscle Contraction | 2 | 2010 | 413 | 0.130 |
Why?
| | Veins | 1 | 2014 | 60 | 0.120 |
Why?
| | Phenotype | 2 | 2021 | 3004 | 0.120 |
Why?
| | Biocompatible Materials | 2 | 2016 | 378 | 0.120 |
Why?
| | Models, Anatomic | 1 | 2014 | 94 | 0.120 |
Why?
| | Surface Properties | 3 | 2012 | 397 | 0.120 |
Why?
| | SKP Cullin F-Box Protein Ligases | 1 | 2013 | 10 | 0.120 |
Why?
| | Thermometry | 1 | 2013 | 2 | 0.120 |
Why?
| | Tripartite Motif Proteins | 1 | 2013 | 31 | 0.120 |
Why?
| | Internet | 1 | 2018 | 633 | 0.110 |
Why?
| | Electrocoagulation | 1 | 2013 | 36 | 0.110 |
Why?
| | Neurogenesis | 1 | 2014 | 105 | 0.110 |
Why?
| | Compliance | 1 | 2012 | 44 | 0.110 |
Why?
| | Vascular Surgical Procedures | 1 | 2015 | 262 | 0.110 |
Why?
| | Proteomics | 1 | 2018 | 876 | 0.110 |
Why?
| | Tooth Calcification | 1 | 2012 | 3 | 0.110 |
Why?
| | Eye | 1 | 2013 | 106 | 0.110 |
Why?
| | Anthropology, Physical | 1 | 2012 | 29 | 0.110 |
Why?
| | Madagascar | 1 | 2012 | 40 | 0.110 |
Why?
| | Catheter Ablation | 1 | 2015 | 286 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 1 | 2015 | 653 | 0.110 |
Why?
| | Cell Death | 1 | 2014 | 339 | 0.110 |
Why?
| | Molar | 1 | 2012 | 45 | 0.110 |
Why?
| | Olfactory Bulb | 1 | 2014 | 125 | 0.110 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2013 | 148 | 0.110 |
Why?
| | Mitochondria | 2 | 2018 | 786 | 0.110 |
Why?
| | Reflex | 1 | 2012 | 64 | 0.100 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2013 | 192 | 0.100 |
Why?
| | Microscopy, Atomic Force | 1 | 2012 | 118 | 0.100 |
Why?
| | Hepatitis A | 4 | 1982 | 27 | 0.100 |
Why?
| | Viscoelastic Substances | 1 | 2011 | 9 | 0.100 |
Why?
| | Muscle Proteins | 1 | 2013 | 219 | 0.100 |
Why?
| | Placental Insufficiency | 1 | 2013 | 104 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2013 | 3173 | 0.100 |
Why?
| | Cell Differentiation | 5 | 2020 | 1753 | 0.100 |
Why?
| | Ecology | 1 | 2012 | 104 | 0.100 |
Why?
| | Primates | 1 | 2012 | 114 | 0.100 |
Why?
| | Video Recording | 1 | 2012 | 156 | 0.100 |
Why?
| | Stress, Physiological | 2 | 2015 | 415 | 0.100 |
Why?
| | Magnetic Resonance Spectroscopy | 1 | 2013 | 508 | 0.100 |
Why?
| | Polymethyl Methacrylate | 1 | 2010 | 20 | 0.100 |
Why?
| | Plastics | 1 | 2010 | 36 | 0.100 |
Why?
| | Electromagnetic Fields | 1 | 2010 | 21 | 0.090 |
Why?
| | Reaction Time | 1 | 2012 | 392 | 0.090 |
Why?
| | Middle Aged | 6 | 2020 | 27627 | 0.090 |
Why?
| | Radiography | 2 | 2011 | 861 | 0.090 |
Why?
| | Action Potentials | 1 | 2013 | 420 | 0.090 |
Why?
| | Data Interpretation, Statistical | 1 | 2012 | 336 | 0.090 |
Why?
| | Analysis of Variance | 1 | 2013 | 1295 | 0.090 |
Why?
| | Time Factors | 6 | 2013 | 6414 | 0.090 |
Why?
| | Cell Proliferation | 3 | 2012 | 2275 | 0.090 |
Why?
| | Gestational Age | 1 | 2012 | 765 | 0.090 |
Why?
| | Gene Expression Profiling | 5 | 2017 | 1597 | 0.090 |
Why?
| | Skin | 1 | 2014 | 657 | 0.090 |
Why?
| | Myoglobin | 1 | 2009 | 15 | 0.090 |
Why?
| | Receptors, Glucocorticoid | 1 | 2010 | 133 | 0.080 |
Why?
| | Viscosity | 1 | 2009 | 83 | 0.080 |
Why?
| | Granulocytes | 1 | 2008 | 79 | 0.080 |
Why?
| | Endothelial Cells | 2 | 2013 | 732 | 0.080 |
Why?
| | Fetus | 1 | 2013 | 690 | 0.080 |
Why?
| | Transcriptome | 3 | 2022 | 756 | 0.080 |
Why?
| | Immunity | 1 | 2009 | 129 | 0.080 |
Why?
| | Interleukin-6 | 2 | 2022 | 692 | 0.080 |
Why?
| | Mice, Inbred BALB C | 2 | 2020 | 1206 | 0.080 |
Why?
| | Lymphocyte Activation | 2 | 2009 | 1067 | 0.080 |
Why?
| | Aged, 80 and over | 2 | 2013 | 6562 | 0.080 |
Why?
| | Nanotechnology | 1 | 2009 | 120 | 0.080 |
Why?
| | Bone Marrow Cells | 1 | 2008 | 273 | 0.080 |
Why?
| | Sulfhydryl Compounds | 2 | 2022 | 179 | 0.080 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2021 | 2179 | 0.080 |
Why?
| | Models, Animal | 2 | 2021 | 363 | 0.080 |
Why?
| | Infant | 8 | 2017 | 8295 | 0.080 |
Why?
| | Regional Blood Flow | 1 | 2009 | 418 | 0.070 |
Why?
| | Brain | 1 | 2018 | 2490 | 0.070 |
Why?
| | Metabolomics | 3 | 2017 | 550 | 0.070 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2513 | 0.070 |
Why?
| | Apoptosis | 1 | 2015 | 2484 | 0.070 |
Why?
| | Body Mass Index | 1 | 2013 | 2092 | 0.070 |
Why?
| | Muscular Disorders, Atrophic | 1 | 2005 | 3 | 0.070 |
Why?
| | Systems Integration | 1 | 2005 | 42 | 0.060 |
Why?
| | Metabolome | 2 | 2018 | 296 | 0.060 |
Why?
| | Men | 1 | 2005 | 21 | 0.060 |
Why?
| | Cell Survival | 3 | 2017 | 1047 | 0.060 |
Why?
| | Sciatic Nerve | 1 | 2005 | 59 | 0.060 |
Why?
| | Hepatitis B | 4 | 1982 | 52 | 0.060 |
Why?
| | Infant, Newborn | 5 | 2013 | 5256 | 0.060 |
Why?
| | Adult | 9 | 2013 | 31525 | 0.060 |
Why?
| | Pregnancy Complications | 1 | 2009 | 448 | 0.060 |
Why?
| | Cytokines | 2 | 2009 | 1900 | 0.060 |
Why?
| | Diaphyses | 1 | 2003 | 15 | 0.060 |
Why?
| | Hypertension | 1 | 2012 | 1203 | 0.060 |
Why?
| | Endothelium, Vascular | 1 | 2010 | 907 | 0.060 |
Why?
| | United States | 1 | 2020 | 12557 | 0.060 |
Why?
| | Fascia | 1 | 2023 | 17 | 0.060 |
Why?
| | Adolescent | 9 | 2017 | 18483 | 0.060 |
Why?
| | In Vitro Techniques | 2 | 2015 | 1096 | 0.060 |
Why?
| | Ligaments | 1 | 2023 | 47 | 0.060 |
Why?
| | Polystyrenes | 1 | 2022 | 33 | 0.050 |
Why?
| | Lung | 1 | 2015 | 3666 | 0.050 |
Why?
| | Biomarkers | 4 | 2016 | 3590 | 0.050 |
Why?
| | Equipment Design | 2 | 2014 | 519 | 0.050 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2018 | 3361 | 0.050 |
Why?
| | Myocardium | 2 | 1997 | 970 | 0.050 |
Why?
| | Genes, MHC Class II | 1 | 2002 | 72 | 0.050 |
Why?
| | Uterus | 1 | 2023 | 197 | 0.050 |
Why?
| | RNA, Messenger | 5 | 2016 | 2661 | 0.050 |
Why?
| | Meniscus | 1 | 2021 | 22 | 0.050 |
Why?
| | Chondrogenesis | 1 | 2021 | 80 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2008 | 1774 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2002 | 256 | 0.050 |
Why?
| | Guanidinoacetate N-Methyltransferase | 1 | 2020 | 5 | 0.050 |
Why?
| | Biophysics | 1 | 2020 | 73 | 0.050 |
Why?
| | Corticosterone | 2 | 2017 | 253 | 0.050 |
Why?
| | International Cooperation | 1 | 2001 | 177 | 0.050 |
Why?
| | Cell Culture Techniques | 1 | 2022 | 356 | 0.050 |
Why?
| | Hyaluronic Acid | 1 | 2002 | 197 | 0.050 |
Why?
| | Rats, Wistar | 1 | 2021 | 399 | 0.040 |
Why?
| | Protein Isoforms | 1 | 2001 | 345 | 0.040 |
Why?
| | Bone Substitutes | 1 | 1999 | 30 | 0.040 |
Why?
| | Durapatite | 1 | 1999 | 33 | 0.040 |
Why?
| | Dietary Sucrose | 1 | 2000 | 55 | 0.040 |
Why?
| | Hydrostatic Pressure | 1 | 2019 | 18 | 0.040 |
Why?
| | Osseointegration | 1 | 1999 | 37 | 0.040 |
Why?
| | Extremities | 1 | 2020 | 113 | 0.040 |
Why?
| | Diet, High-Fat | 1 | 2021 | 247 | 0.040 |
Why?
| | Forecasting | 1 | 2001 | 354 | 0.040 |
Why?
| | Lymphocyte Count | 2 | 2009 | 136 | 0.040 |
Why?
| | Humerus | 1 | 1998 | 44 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 109 | 0.040 |
Why?
| | Intracellular Space | 1 | 2018 | 69 | 0.040 |
Why?
| | Signal Transduction | 3 | 2018 | 4713 | 0.040 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 195 | 0.040 |
Why?
| | Interprofessional Relations | 1 | 2001 | 262 | 0.040 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 1 | 2019 | 160 | 0.040 |
Why?
| | Gray Matter | 1 | 2018 | 66 | 0.040 |
Why?
| | Glycoproteins | 1 | 2000 | 319 | 0.040 |
Why?
| | Cell Cycle | 1 | 2001 | 550 | 0.040 |
Why?
| | Femur Neck | 1 | 2018 | 65 | 0.040 |
Why?
| | Osteoporotic Fractures | 1 | 2018 | 51 | 0.040 |
Why?
| | Receptors, Corticotropin | 1 | 2017 | 2 | 0.040 |
Why?
| | Young Adult | 1 | 2013 | 10799 | 0.040 |
Why?
| | Sarcomeres | 1 | 1997 | 91 | 0.040 |
Why?
| | Glycolysis | 1 | 2018 | 224 | 0.040 |
Why?
| | Dietary Fats | 1 | 2000 | 325 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 770 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2002 | 980 | 0.040 |
Why?
| | Immune System Diseases | 1 | 2017 | 35 | 0.040 |
Why?
| | Polymerization | 1 | 2017 | 129 | 0.040 |
Why?
| | Catecholamines | 1 | 2017 | 100 | 0.040 |
Why?
| | White Matter | 1 | 2018 | 115 | 0.040 |
Why?
| | Severity of Illness Index | 1 | 2005 | 2674 | 0.040 |
Why?
| | Diabetes Complications | 1 | 2018 | 219 | 0.040 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 10 | 0.040 |
Why?
| | Lipid Droplets | 1 | 2016 | 21 | 0.040 |
Why?
| | PPAR alpha | 1 | 2016 | 56 | 0.040 |
Why?
| | Adhesiveness | 1 | 2015 | 19 | 0.030 |
Why?
| | Click Chemistry | 1 | 2016 | 51 | 0.030 |
Why?
| | Metabolic Diseases | 1 | 2017 | 103 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2020 | 788 | 0.030 |
Why?
| | Systems Biology | 1 | 2016 | 57 | 0.030 |
Why?
| | Leukocytes | 1 | 2017 | 290 | 0.030 |
Why?
| | RANK Ligand | 1 | 2015 | 28 | 0.030 |
Why?
| | Osteocalcin | 1 | 2015 | 35 | 0.030 |
Why?
| | Phagocytosis | 1 | 2017 | 364 | 0.030 |
Why?
| | Light | 1 | 2017 | 342 | 0.030 |
Why?
| | DNA Primers | 2 | 2010 | 533 | 0.030 |
Why?
| | Flow Cytometry | 2 | 2008 | 1085 | 0.030 |
Why?
| | Bone Density Conservation Agents | 1 | 2015 | 61 | 0.030 |
Why?
| | Surgical Equipment | 1 | 2014 | 13 | 0.030 |
Why?
| | Alkaline Phosphatase | 1 | 2015 | 158 | 0.030 |
Why?
| | Reactive Oxygen Species | 1 | 2017 | 576 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2015 | 180 | 0.030 |
Why?
| | Genetic Predisposition to Disease | 1 | 2022 | 2275 | 0.030 |
Why?
| | DNA Fragmentation | 1 | 2013 | 48 | 0.030 |
Why?
| | Shear Strength | 1 | 2013 | 55 | 0.030 |
Why?
| | Cell Adhesion | 1 | 2015 | 443 | 0.030 |
Why?
| | Child, Preschool | 7 | 2017 | 9493 | 0.030 |
Why?
| | Oncogene Proteins | 1 | 2013 | 52 | 0.030 |
Why?
| | Electric Impedance | 1 | 2013 | 101 | 0.030 |
Why?
| | Adaptation, Physiological | 2 | 2008 | 502 | 0.030 |
Why?
| | Hyalin | 1 | 2012 | 5 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 1997 | 815 | 0.030 |
Why?
| | Base Sequence | 2 | 2010 | 2160 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2009 | 1947 | 0.030 |
Why?
| | Hepatitis, Viral, Human | 2 | 1982 | 26 | 0.030 |
Why?
| | Transcription, Genetic | 1 | 1997 | 1323 | 0.030 |
Why?
| | Stem Cells | 1 | 2015 | 559 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2005 | 9346 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 940 | 0.020 |
Why?
| | Umbilical Veins | 1 | 2010 | 59 | 0.020 |
Why?
| | Molecular Structure | 1 | 2011 | 459 | 0.020 |
Why?
| | Fluorescent Antibody Technique, Indirect | 2 | 2001 | 55 | 0.020 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2010 | 198 | 0.020 |
Why?
| | Hemoglobin H | 1 | 1989 | 1 | 0.020 |
Why?
| | Thalassemia | 1 | 1989 | 7 | 0.020 |
Why?
| | Aged | 4 | 2003 | 19661 | 0.020 |
Why?
| | Hemoglobins, Abnormal | 1 | 1989 | 10 | 0.020 |
Why?
| | Antibodies, Viral | 3 | 1982 | 542 | 0.020 |
Why?
| | Antigens, Ly | 1 | 2008 | 45 | 0.020 |
Why?
| | CD11b Antigen | 1 | 2008 | 59 | 0.020 |
Why?
| | Antigens, Differentiation | 1 | 2008 | 79 | 0.020 |
Why?
| | Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2008 | 55 | 0.020 |
Why?
| | Hyaluronan Receptors | 1 | 2008 | 93 | 0.020 |
Why?
| | Leukocyte Count | 1 | 2009 | 305 | 0.020 |
Why?
| | Child | 7 | 2017 | 19137 | 0.020 |
Why?
| | Cell Count | 1 | 2008 | 315 | 0.020 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2008 | 129 | 0.020 |
Why?
| | Immunophenotyping | 1 | 2008 | 278 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2013 | 601 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-fos | 1 | 2008 | 193 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 982 | 0.020 |
Why?
| | Genetic Markers | 1 | 1989 | 348 | 0.020 |
Why?
| | Obesity | 1 | 2021 | 2751 | 0.020 |
Why?
| | Epidemiologic Methods | 3 | 1982 | 72 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2010 | 527 | 0.020 |
Why?
| | Microscopy, Fluorescence | 2 | 2001 | 412 | 0.020 |
Why?
| | DNA Replication | 1 | 2008 | 211 | 0.020 |
Why?
| | Cell Lineage | 1 | 2008 | 318 | 0.020 |
Why?
| | Radiation Dosage | 1 | 2008 | 147 | 0.020 |
Why?
| | Hepatitis B Surface Antigens | 3 | 1982 | 19 | 0.020 |
Why?
| | Transfection | 2 | 2001 | 890 | 0.020 |
Why?
| | Blood Pressure | 1 | 2013 | 1664 | 0.020 |
Why?
| | Australia | 3 | 1982 | 212 | 0.020 |
Why?
| | Killer Cells, Natural | 1 | 2008 | 381 | 0.020 |
Why?
| | Up-Regulation | 1 | 2009 | 872 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2009 | 870 | 0.020 |
Why?
| | Nerve Compression Syndromes | 1 | 2005 | 30 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 9003 | 0.020 |
Why?
| | Nitric Oxide | 1 | 2010 | 893 | 0.020 |
Why?
| | Pilot Projects | 1 | 2009 | 1420 | 0.020 |
Why?
| | Hepatovirus | 2 | 1982 | 3 | 0.020 |
Why?
| | Hepatitis B Core Antigens | 2 | 1981 | 5 | 0.010 |
Why?
| | Hepatitis B Antibodies | 2 | 1981 | 10 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 2 | 2000 | 2478 | 0.010 |
Why?
| | B-Lymphocytes | 1 | 2008 | 770 | 0.010 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1167 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2010 | 4081 | 0.010 |
Why?
| | Cell Line | 1 | 2008 | 2707 | 0.010 |
Why?
| | Papua New Guinea | 1 | 1981 | 7 | 0.010 |
Why?
| | MyoD Protein | 1 | 2001 | 28 | 0.010 |
Why?
| | Altitude | 2 | 1981 | 422 | 0.010 |
Why?
| | Maxillofacial Prosthesis Implantation | 1 | 1999 | 3 | 0.010 |
Why?
| | Placebos | 1 | 2000 | 202 | 0.010 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2000 | 147 | 0.010 |
Why?
| | Antigens, Viral | 1 | 1980 | 181 | 0.010 |
Why?
| | Disease Outbreaks | 1 | 1982 | 322 | 0.010 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 1998 | 61 | 0.010 |
Why?
| | Myosin Light Chains | 1 | 1997 | 35 | 0.010 |
Why?
| | Troponin | 1 | 1997 | 47 | 0.010 |
Why?
| | Crosses, Genetic | 1 | 1997 | 138 | 0.010 |
Why?
| | Troponin T | 1 | 1997 | 50 | 0.010 |
Why?
| | Mice, Inbred DBA | 1 | 1997 | 174 | 0.010 |
Why?
| | Tropomyosin | 1 | 1997 | 13 | 0.010 |
Why?
| | Muscle Development | 1 | 1997 | 102 | 0.010 |
Why?
| | Molecular Weight | 1 | 1997 | 343 | 0.010 |
Why?
| | Cell Movement | 1 | 2001 | 897 | 0.010 |
Why?
| | Age Factors | 2 | 1981 | 2995 | 0.010 |
Why?
| | Animals, Newborn | 1 | 1997 | 806 | 0.010 |
Why?
| | Mice, Knockout | 1 | 2002 | 2680 | 0.010 |
Why?
| | Heart | 1 | 1997 | 631 | 0.010 |
Why?
| | Prospective Studies | 2 | 1981 | 6477 | 0.010 |
Why?
| | Hepatitis C | 2 | 1982 | 217 | 0.010 |
Why?
| | Radioimmunoassay | 1 | 1982 | 165 | 0.000 |
Why?
| | New Guinea | 1 | 1981 | 4 | 0.000 |
Why?
| | Immunoglobulins | 1 | 1982 | 154 | 0.000 |
Why?
| | Injections | 1 | 1982 | 167 | 0.000 |
Why?
| | Family Health | 1 | 1982 | 201 | 0.000 |
Why?
| | Immunoglobulin M | 1 | 1982 | 253 | 0.000 |
Why?
| | Follow-Up Studies | 1 | 1982 | 4596 | 0.000 |
Why?
|
|
Ferguson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|